ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko05340	Primary immunodeficiency	12/179	30/7206	2.23803711569e-12
ko05152	Tuberculosis	25/179	187/7206	3.40127457245e-12
ko04380	Osteoclast differentiation	20/179	134/7206	7.66647408151e-11
ko04060	Cytokine-cytokine receptor interaction	23/179	191/7206	2.33318982235e-10
ko04650	Natural killer cell mediated cytotoxicity	16/179	97/7206	1.47538726323e-09
ko05145	Toxoplasmosis	18/179	126/7206	1.49703886904e-09
ko04612	Antigen processing and presentation	14/179	77/7206	4.392435755e-09
ko05150	Staphylococcus aureus infection	10/179	36/7206	1.01107615009e-08
ko05140	Leishmaniasis	13/179	75/7206	2.93034092874e-08
ko04659	Th17 cell differentiation	15/179	106/7206	4.24601352301e-08
ko04621	NOD-like receptor signaling pathway	18/179	157/7206	5.21775817584e-08
ko04064	NF-kappa B signaling pathway	14/179	96/7206	8.28856274872e-08
ko05164	Influenza A	18/179	167/7206	1.36003793878e-07
ko05162	Measles	15/179	120/7206	2.28688582548e-07
ko04660	T cell receptor signaling pathway	15/179	124/7206	3.53593579639e-07
ko05168	Herpes simplex infection	18/179	182/7206	5.0127529208e-07
ko05321	Inflammatory bowel disease (IBD)	10/179	56/7206	9.20791644434e-07
ko05144	Malaria	9/179	45/7206	1.20783559939e-06
ko05330	Allograft rejection	7/179	24/7206	1.25690819746e-06
ko05320	Autoimmune thyroid disease	7/179	29/7206	5.1022662885e-06
ko04620	Toll-like receptor signaling pathway	12/179	100/7206	5.97389018398e-06
ko04630	Jak-STAT signaling pathway	13/179	132/7206	2.16913927916e-05
ko04658	Th1 and Th2 cell differentiation	11/179	96/7206	2.30151539639e-05
ko04640	Hematopoietic cell lineage	9/179	64/7206	2.50073886653e-05
ko05310	Asthma	5/179	17/7206	4.34259578323e-05
ko04145	Phagosome	14/179	162/7206	4.56982817017e-05
ko05133	Pertussis	10/179	87/7206	5.31594282551e-05
ko05332	Graft-versus-host disease	5/179	18/7206	5.89245313568e-05
ko04610	Complement and coagulation cascades	9/179	79/7206	0.000135720280915
ko04672	Intestinal immune network for IgA production	6/179	37/7206	0.000264682261863
ko05167	Kaposi's sarcoma-associated herpesvirus infection	14/179	191/7206	0.000267536030752
ko04662	B cell receptor signaling pathway	9/179	88/7206	0.000311089964844
ko03050	Proteasome	7/179	54/7206	0.00034289490891
ko05161	Hepatitis B	13/179	173/7206	0.000348919215018
ko05142	Chagas disease (American trypanosomiasis)	11/179	130/7206	0.000364962696695
ko04514	Cell adhesion molecules (CAMs)	11/179	130/7206	0.000364962696695
ko05416	Viral myocarditis	7/179	55/7206	0.000384783491858
ko04062	Chemokine signaling pathway	14/179	201/7206	0.000451267881177
ko04217	Necroptosis	13/179	178/7206	0.000459672549084
ko04666	Fc gamma R-mediated phagocytosis	10/179	122/7206	0.000865969852867
ko05131	Shigellosis	8/179	82/7206	0.000921436712613
ko04940	Type I diabetes mellitus	5/179	32/7206	0.00104460672584
ko05166	HTLV-I infection	17/179	292/7206	0.00145304269797
ko04622	RIG-I-like receptor signaling pathway	6/179	62/7206	0.00419416330593
ko05160	Hepatitis C	10/179	153/7206	0.00465798331942
ko04210	Apoptosis	11/179	180/7206	0.00507436805637
ko05323	Rheumatoid arthritis	7/179	89/7206	0.00645025927912
ko05132	Salmonella infection	7/179	98/7206	0.0107588735557
ko05146	Amoebiasis	7/179	99/7206	0.0113418226092
ko04664	Fc epsilon RI signaling pathway	6/179	77/7206	0.0119292209263
ko04144	Endocytosis	16/179	342/7206	0.0122642771114
ko04670	Leukocyte transendothelial migration	9/179	151/7206	0.0126835248074
ko04668	TNF signaling pathway	7/179	120/7206	0.0294832444173
ko00601	Glycosphingolipid biosynthesis - lacto and neolacto series	3/179	28/7206	0.0313140996871
ko04142	Lysosome	8/179	151/7206	0.0340706216006
ko05100	Bacterial invasion of epithelial cells	6/179	99/7206	0.0362179750625
ko05169	Epstein-Barr virus infection	10/179	206/7206	0.0374112564233
ko05130	Pathogenic Escherichia coli infection	5/179	77/7206	0.0420578147593
ko05143	African trypanosomiasis	3/179	32/7206	0.0441352430928
ko05016	Huntington's disease	1/179	215/7206	0.0453256601022